CLINICAL_TRIALS
trial_result
· 2018-10-23
Clinical Trial Update: Multiple Ascending Dose Study of the Safety, Tolerability, Pharmacokinetic/Efficacy [Phase 2]
Summary
Phase 2 multiple ascending dose study in schizophrenia completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Indivior Inc. | Conditions: Schizophrenia | Phase 2 | Status: COMPLETED | Results posted: 2018-10-23